If you may be in danger, call or text 988. Call 911 for emergencies. More crisis resources
For education, not medical advice. Always talk with your own doctor or prescriber about your treatment.

Antidepressants for elderly patients, ranked

Which antidepressants are best for older adults, and which to avoid. Sertraline, escitalopram, and mirtazapine are usually first-line. Paroxetine and TCAs are usually avoided (Beers Criteria). Special considerations for hyponatremia, falls, drug interactions, and dementia.

First-line options

Sertraline (Zoloft): Best safety data in older adults. Effective for depression and anxiety. Lower QTc effect than citalopram. Modest CYP2D6 inhibition. Standard starting dose 25 to 50 mg with slower titration than in younger adults.

Escitalopram (Lexapro): Second common first-line. Well tolerated, minimal anticholinergic, minimal drug interactions. Dose-limited in older adults by QT concerns; usually 10 mg max though some clinicians go to 20 mg.

Mirtazapine (Remeron): Excellent for elderly patients with insomnia, appetite loss, weight loss, or anxiety-predominant depression. Weight gain is desirable in many older patients. Sedation is often welcome. Low sexual side effect rate. Low fall risk despite sedation because of relative preservation of psychomotor function.

Second-line options

Bupropion (Wellbutrin): For patients where sexual side effects or weight gain are unacceptable. No hyponatremia risk. Not for patients with seizure disorder, eating disorder history, or significant anxiety component.

Duloxetine (Cymbalta): For depression with comorbid pain, particularly diabetic neuropathy or fibromyalgia. Watch blood pressure.

Venlafaxine (Effexor): Effective but higher BP concerns and discontinuation syndrome risk than SSRIs. Not usually first-line in elderly.

Vortioxetine (Trintellix): Some cognitive-enhancing data. Low sexual side effects. Expensive. Occasional use in elderly patients where cognition is a specific concern.

Drugs to usually avoid

Paroxetine (Paxil): Beers Criteria. Strong anticholinergic activity contributes to cognitive impairment, dry mouth, constipation, and falls. Sexual side effects highest among SSRIs.

TCAs (amitriptyline, imipramine, doxepin at higher doses): Beers Criteria for most TCAs. Anticholinergic burden, orthostasis, QT prolongation, cardiac conduction effects. Doxepin at low dose (3 to 6 mg) for insomnia is an exception (approved for older adults).

Nefazodone: Hepatotoxicity risk. Rarely used.

Key considerations in elderly patients

Hyponatremia risk: SSRIs cause SIADH in 5 to 30 percent of older adults. See our hyponatremia side effect page. Baseline sodium check and 2-week recheck are reasonable. Sertraline may have slightly lower risk than escitalopram or citalopram.

Fall risk: All antidepressants modestly increase falls. SSRIs plus hyponatremia may explain some falls attributed to sedation.

QTc prolongation: Citalopram dose limited to 20 mg above age 60. Escitalopram less concerning. TCAs and some antipsychotics are more concerning. See our QTc page.

Anticholinergic burden: Paroxetine and TCAs contribute meaningfully. See our anticholinergic burden page.

Bleeding risk: SSRIs plus NSAIDs (often used for arthritis) plus anticoagulation is a common triple. See our SSRI plus NSAIDs page.

Drug interactions: Older adults often on many medications. Fluoxetine and paroxetine are strong CYP2D6 inhibitors and complicate polypharmacy.

Dementia and cognition: Trazodone and mirtazapine are sometimes preferred in patients with cognitive impairment for lower anticholinergic burden. Recent BMJ data (Coupland 2019) suggests paroxetine and amitriptyline have larger dementia signals with prolonged use.

Dosing principles

  • Start at 25 to 50 percent of the usual adult starting dose
  • Titrate slowly (every 2 to 4 weeks vs weekly in younger adults)
  • Target dose often the middle of the usual adult range
  • Response can take 6 to 12 weeks vs 4 to 8 weeks in younger adults
  • Response monitoring using PHQ-9 or geriatric depression scale

Common questions

Is sertraline safe for a 75-year-old? Generally yes. Start at 25 mg, titrate slowly. Check baseline sodium and recheck at 2 weeks. Watch for falls, GI symptoms.

Which antidepressant is safest for someone with dementia? Sertraline or mirtazapine are usually first choices. Trazodone at low dose is sometimes used for combined depression and insomnia. Avoid paroxetine and TCAs.

How long should treatment continue? For first depressive episode, 6 to 12 months after remission. For recurrent depression or severe depression, indefinite treatment is often appropriate.

Should elderly patients be on lower doses long-term? Not automatically. Reaching an effective dose matters more than staying low. Some older adults need doses similar to younger adults. Dose adjustment is empirical.

What about combining antidepressants in elderly patients? Combinations are done with caution. Common: SSRI plus bupropion for partial response or sexual side effects; SSRI plus mirtazapine for depression with prominent insomnia and weight loss. Avoid combinations with high serotonin syndrome or bleeding risk.

Sources

  • American Geriatrics Society 2023 Updated AGS Beers Criteria. J Am Geriatr Soc. 2023;71(7):2052-2081.
  • Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia: a nested case-control study. BMJ. 2019;367:l6754.
  • Kok RM, Reynolds CF 3rd. Management of depression in older adults: a review. JAMA. 2017;317(20):2114-2122.
  • FDA Drug Safety Communication: revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses. August 24, 2011.

THE KNOWLEDGE PATH

Walk this topic outward.

  1. GUIDE Antidepressants for elderly patients, ranked (current)
  2. CLASS SSRIs
  3. MEDICATION Sertraline (Zoloft)
  4. CONDITION Major Depressive Disorder (on Shrinkopedia)
  5. CARE Depression care at shrinkMD

The Knowledge Path is a curated walk. Every step is one decision away from the next.

Your next step in The Shrink Network

You are here: PsychiatryRx, the medication education layer of The Shrink Network.

Every site in the network does one job. No matter where you start, we help you find the next step that makes sense.

Medication management at shrinkMD

shrinkMD is the network's independent telepsychiatry practice, founded by our medical editor. It's one option among many. PsychiatryRx runs no ads, sells nothing, and earns no referral fees.

Want to understand more first?

Managing a medication needs a prescriber

Any psychiatric medication has to be started and adjusted by a clinician who can follow you over time. If you don't have a prescriber, our guides section explains the options, including in-person care and telepsychiatry, and how to choose between them.